Kentucky Retirement Systems’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,548
Closed -$655K 514
2024
Q4
$655K Sell
3,548
-49
-1% -$9.44K 0.02% 463
2024
Q3
$709K Sell
3,597
-285
-7% -$59.2K 0.02% 466
2024
Q2
$802K Sell
3,882
-14
-0.4% -$3.17K 0.02% 454
2024
Q1
$1.06M Sell
3,896
-208
-5% -$49.7K 0.03% 427
2023
Q4
$970K Buy
4,104
+24
+0.6% +$4.72K 0.03% 437
2023
Q3
$800K Sell
4,080
-35
-0.9% -$7.19K 0.03% 447
2023
Q2
$865K Buy
4,115
+92
+2% +$18.3K 0.03% 447
2023
Q1
$812K Buy
4,023
+24
+0.6% +$5.44K 0.03% 451
2022
Q4
$871K Buy
3,999
+18
+0.5% +$3.93K 0.03% 431
2022
Q3
$783K Buy
3,981
+210
+6% +$45.3K 0.03% 436
2022
Q2
$807K Buy
3,771
+554
+17% +$135K 0.03% 437
2022
Q1
$914K Buy
3,217
+181
+6% +$55.8K 0.04% 422
2021
Q4
$1.14M Buy
3,036
+70
+2% +$27.2K 0.05% 368
2021
Q3
$1.22M Buy
2,966
+40
+1% +$16.6K 0.06% 321
2021
Q2
$1.08M Buy
+2,926
New +$977K 0.05% 354

Other funds holding CRL

Kentucky Retirement Systems's CRL Position: Q1 2025 in Review

Kentucky Retirement Systems sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 3,548 shares — an estimated $655K sold.

Kentucky Retirement Systems first reported a position in CRL in Q2 2021 and held it in 15 quarters. The position peaked at $1.22M in Q3 2021. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

  • Kentucky Retirement Systems reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
  • Kentucky Retirement Systems sold 3,548 Charles River Laboratories shares in Q1 2025, an estimated $655K.
  • Kentucky Retirement Systems first reported a position in Charles River Laboratories in Q2 2021 and held it in 15 quarters.
  • Kentucky Retirement Systems's Charles River Laboratories position peaked at $1.22M in Q3 2021.
  • 561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on Kentucky Retirement Systems's 13F filing for Q1 2025, filed 22 Apr 2025.